HHS awards $57.5M contract for Medicare drug provision support, with 6 bids received

Contract Overview

Contract Amount: $57,472,437 ($57.5M)

Contractor: Research Triangle Institute

Awarding Agency: Department of Health and Human Services

Start Date: 2024-07-17

End Date: 2027-02-19

Contract Duration: 947 days

Daily Burn Rate: $60.7K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 6

Pricing Type: TIME AND MATERIALS

Sector: Healthcare

Official Description: DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS)

Place of Performance

Location: DURHAM, DURHAM County, NORTH CAROLINA, 27709

State: North Carolina Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $57.5 million to RESEARCH TRIANGLE INSTITUTE for work described as: DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) Key points: 1. Contract aims to support the implementation of Medicare prescription drug provisions under the Inflation Reduction Act. 2. The contract was awarded using full and open competition, indicating a broad search for qualified contractors. 3. Research Triangle Institute, the contractor, has a track record in research and program support. 4. The contract duration is approximately 2.5 years, suggesting a medium-term engagement for critical support. 5. The North Carolina location of the contractor may have implications for regional economic impact. 6. The contract type is Time and Materials, which requires careful monitoring of labor hours and rates.

Value Assessment

Rating: good

The contract value of $57.5 million over roughly 2.5 years appears reasonable for the scope of supporting complex Medicare prescription drug provisions. Benchmarking against similar large-scale federal program support contracts suggests this is within expected ranges. The Time and Materials pricing structure necessitates diligent oversight to ensure costs remain aligned with the value delivered and market labor rates.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded through full and open competition, with six bids received. This level of competition is generally positive, suggesting that multiple capable vendors were interested and had the opportunity to propose. A competitive process helps ensure that the government receives fair pricing and the best value, as contractors vie to win the award.

Taxpayer Impact: The full and open competition indicates that taxpayer dollars are being used efficiently by allowing a wide range of potential contractors to bid, driving down costs and ensuring a robust selection process.

Public Impact

Beneficiaries: Medicare beneficiaries will indirectly benefit from improved implementation of drug cost-saving measures. Services Delivered: The contract supports the operationalization and implementation of key Medicare drug provisions. Geographic Impact: While the primary impact is national for Medicare, the contractor's location in North Carolina may provide some local economic stimulus. Workforce Implications: The contract will likely involve a team of analysts, researchers, and program specialists, potentially creating jobs within the contractor's organization.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Time and Materials (T&M) contract type can lead to cost overruns if not closely managed.
The scope of 'implementation and operationalization' is broad and may present challenges in defining clear deliverables.
Reliance on a single contractor for critical implementation support could pose a risk if performance falters.

Positive Signals

Awarded through full and open competition, suggesting a competitive pricing environment.
The contractor, Research Triangle Institute, has a history of performing government contracts.
The contract directly supports a high-priority legislative initiative (Inflation Reduction Act drug provisions).

Sector Analysis

This contract falls within the professional, scientific, and technical services sector, specifically management consulting. The market for supporting federal health programs, particularly those related to Medicare and prescription drugs, is substantial. This contract is a key component in the government's effort to implement significant policy changes aimed at reducing drug costs for beneficiaries.

Small Business Impact

There is no indication of a small business set-aside for this contract, nor are there explicit requirements for subcontracting with small businesses mentioned in the provided data. This suggests that the primary focus was on securing the best overall proposal through open competition, rather than specifically targeting small business participation.

Oversight & Accountability

Oversight will likely be managed by the Centers for Medicare and Medicaid Services (CMS) program officials. The Time and Materials contract type necessitates rigorous monitoring of labor hours, rates, and direct costs to ensure accountability and prevent overspending. Transparency will depend on CMS's reporting practices and any Inspector General involvement in reviewing program expenditures.

Related Government Programs

Medicare Prescription Drug Benefit Program
Inflation Reduction Act Implementation
Health Policy Analysis
Federal Program Management Support
Centers for Medicare and Medicaid Services Contracts

Risk Flags

Potential for cost overruns due to T&M contract type.
Complexity of implementing IRA drug provisions may lead to scope creep.
Ensuring effective performance monitoring and accountability for a large support contract.

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $57.5 million to RESEARCH TRIANGLE INSTITUTE. DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS)

Who is the contractor on this award?

The obligated recipient is RESEARCH TRIANGLE INSTITUTE.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Centers for Medicare and Medicaid Services).

What is the total obligated amount?

The obligated amount is $57.5 million.

What is the period of performance?

Start: 2024-07-17. End: 2027-02-19.

What is the specific expertise Research Triangle Institute brings to supporting Medicare prescription drug provisions?

Research Triangle Institute (RTI) is a non-profit research institute with extensive experience in health policy, program evaluation, and technical assistance for government agencies. They have a strong background in areas relevant to Medicare, including prescription drug policy, health economics, and the operational aspects of large-scale healthcare programs. RTI's expertise likely encompasses data analysis, stakeholder engagement, policy interpretation, and the development of implementation strategies, all of which are critical for supporting the complex prescription drug provisions mandated by the Inflation Reduction Act. Their track record includes numerous projects for agencies like HHS, suggesting a deep understanding of federal contracting and program requirements.

How does the Time and Materials (T&M) contract type impact cost control for this $57.5 million award?

The Time and Materials (T&M) contract type means the government pays the contractor based on the actual labor hours worked and the cost of materials used, plus a fixed fee or hourly rate. For a contract of this magnitude ($57.5 million), T&M requires robust government oversight to control costs effectively. Without strict monitoring of labor categories, hours billed, and material expenses, there is a risk of cost overruns. The Centers for Medicare and Medicaid Services (CMS) must actively manage the scope of work, ensure efficient use of contractor resources, and regularly audit invoices to ensure that payments are fair and reasonable, aligning with market rates and the value delivered.

What are the potential risks associated with implementing the Inflation Reduction Act's Medicare drug provisions?

Implementing the Inflation Reduction Act's Medicare drug provisions presents several risks. These include the complexity of negotiating drug prices, potential legal challenges from pharmaceutical companies, ensuring equitable access to medications for all beneficiaries, and managing the administrative burden on both CMS and healthcare providers. There's also a risk of unintended consequences, such as impacts on pharmaceutical innovation or drug supply chains. The success of these provisions hinges on effective policy design, clear communication, and seamless operationalization, which this contract aims to support. Failure in implementation could lead to continued high drug costs or disruptions in patient care.

How does the number of bidders (6) in this full and open competition reflect market conditions for this type of service?

Receiving six bids in a full and open competition for a contract supporting Medicare prescription drug provisions suggests a healthy and competitive market for these specialized services. This number indicates that multiple firms possess the necessary expertise and capacity to undertake such a significant federal undertaking. A competitive landscape generally benefits the government by providing a wider range of options, fostering innovation, and driving down prices. It suggests that the contract's scope and requirements were well-defined enough to attract substantial interest, while also indicating that the government successfully reached a broad base of potential contractors.

What is the historical spending trend for similar administrative and management consulting services within HHS?

Historical spending by the Department of Health and Human Services (HHS) on administrative management and general management consulting services (NAICS code 541611) has been substantial, reflecting the complexity and scale of its operations. HHS agencies, including CMS, frequently contract for expert support in areas such as policy implementation, program management, data analysis, and strategic planning. While specific figures for contracts directly analogous to this one are not provided, the overall trend shows a consistent reliance on external expertise to navigate intricate healthcare regulations, manage large federal programs, and adapt to legislative changes like the Inflation Reduction Act. This contract aligns with that established pattern of seeking specialized support.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Administrative Management and General Management Consulting Services

Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › PROFESSIONAL SERVICES

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Solicitation ID: 240242

Offers Received: 6

Pricing Type: TIME AND MATERIALS (Y)

Evaluated Preference: NONE

Contractor Details

Address: 3040 CORNWALLIS RD, DURHAM, NC, 27709

Business Categories: Category Business, Corporate Entity Tax Exempt, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $147,982,391

Exercised Options: $57,472,437

Current Obligation: $57,472,437

Actual Outlays: $14,121,307

Subaward Activity

Number of Subawards: 15

Total Subaward Amount: $11,158,813

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Parent Contract

Parent Award PIID: GS00F354CA

IDV Type: FSS

Timeline